{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:24:39Z","timestamp":1790061879924,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004933","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Toxinas","doi-asserted-by":"publisher","award":["010627\/2011-1"],"award-info":[{"award-number":["010627\/2011-1"]}],"id":[{"id":"10.13039\/501100004933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004933","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Toxinas","doi-asserted-by":"publisher","award":["PPSUS\/FAPERO\/MS\/2013 n.01.1131.00033-0013\/2013"],"award-info":[{"award-number":["PPSUS\/FAPERO\/MS\/2013 n.01.1131.00033-0013\/2013"]}],"id":[{"id":"10.13039\/501100004933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["027652\/2014"],"award-info":[{"award-number":["027652\/2014"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.intimp.2017.12.012","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T15:05:32Z","timestamp":1513955132000},"page":"128-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["ASP49-phospholipase A2-loaded liposomes as experimental therapy in cutaneous leishmaniasis model"],"prefix":"10.1016","volume":"55","author":[{"given":"Neuza B.","family":"de Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Arag\u00e3o Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e1lia S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika P.","family":"Tagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson M.","family":"Kayano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa D.F.","family":"Nicolete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreimar M.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Nicolete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.12.012_bb0005","author":"WHO\/Leishmaniasis, WHO"},{"key":"10.1016\/j.intimp.2017.12.012_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1590\/S1415-790X2004000300010","article-title":"Leishmaniose tegumentar americana: hist\u00f3rico, epidemiologia e perspectivas de controle","volume":"7","author":"Basano","year":"2004","journal-title":"Rev. Bras. Epidemiol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0015","series-title":"Guia de Vigil\u00e2ncia Epidemiol\u00f3gica, Bras\u00edlia, 6o caderno","first-page":"0","author":"MINIST\u00c9RIO DA SA\u00daDE","year":"2010"},{"key":"10.1016\/j.intimp.2017.12.012_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962007000200002","article-title":"Tratamento da Leishmaniose Tegumentar Americana","volume":"82","author":"de Lima","year":"2007","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S0037-86822008000400022","article-title":"Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis","volume":"41","author":"da Costa Filho","year":"2008","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.intimp.2017.12.012_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S0365-05962009000200004","article-title":"O uso da associa\u00e7\u00e3o azitromicina e N-metil glucamina no tratamento da leishmaniose cut\u00e2nea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6","volume":"84","author":"Sampaio","year":"2009","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2013.06.001","article-title":"Lipases, liposomes and lipid-prodrugs","author":"Arouri","year":"2013","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.intimp.2017.12.012_bb0040","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2017.12.012_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reim\u00e3o","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"DATE","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2017.12.012_bb0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1107\/S1744309106025164","article-title":"Preliminary X-ray crystallographic studies of BthTX-II, a myotoxic Asp49-phospholipase A2 with low catalytic activity from Bothrops jararacussu venom","volume":"62","author":"Corr\u00eaa","year":"2006","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.intimp.2017.12.012_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40409-017-0099-6","article-title":"Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A2","volume":"23","author":"Zambelli","year":"2017","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.intimp.2017.12.012_bb0065","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.peptides.2008.05.021","article-title":"Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells","volume":"29","author":"Costa","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2017.12.012_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.intimp.2016.04.025","article-title":"Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis","volume":"36","author":"De Barros","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.exppara.2013.07.022","article-title":"Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell","volume":"135","author":"Barros","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxicon.2005.04.024","article-title":"Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom","volume":"46","author":"Barbosa","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2017.12.012_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxicon.2005.09.008","article-title":"Isolation of a new L-amino acid oxidase from Crotalus durissus cascavella venom","volume":"47","author":"Toyama","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2017.12.012_bb0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJM198702123160705","article-title":"Cachectin: more than a tumor necrosis factor","volume":"316","author":"Epstein","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2017.12.012_bb0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.exppara.2013.06.006","article-title":"In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity","volume":"135","author":"Bhattacharya","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2017.12.012_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0041-0101(00)00107-0","article-title":"Leucocyte recruitment induced by type II phospholipases A(2) into the rat pleural cavity","volume":"38","author":"de Castro","year":"2000","journal-title":"Toxicon"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:09:18Z","timestamp":1761584958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691730485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"alternative-id":["S156757691730485X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.012","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASP49-phospholipase A2-loaded liposomes as experimental therapy in cutaneous leishmaniasis model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}